HuGE Literature Finder
Records
1
-
2
Second-line dovitinib (TKI258) in patients with FGFR2-mutated or FGFR2-non-mutated advanced or metastatic endometrial cancer: a non-randomised, open-label, two-group, two-stage, phase 2 study. The Lancet. Oncology 2015 Jun 16 (6): 686-94. Konecny Gottfried E, Finkler Neil, Garcia Agustin A, Lorusso Domenica, Lee Paula S, Rocconi Rodney P, Fong Peter C, Squires Matt, Mishra Kaushal, Upalawanna Allison, Wang Yongyu, Kristeleit Rebec |
High risk of endometrial cancer in colorectal cancer kindred is pathognomonic for MMR-mutation carriers. Familial cancer 2009 8 (2): 145-51. Grindedal Eli Marie, Blanco Ignacio, Stormorken Astrid, Maehle Lovise, Clark Neal, González Sara, Capella Gabriel, Vasen Hans, Burn John, Møller P |
- Page last reviewed:Oct 1, 2021
- Page last updated:May 20, 2022
- Content source: